Neurol. praxi. 2022;23(2):176-178 | DOI: 10.36290/neu.2022.025

Hemostyptika u pacientů s rupturou aneuryzmatu
NE!

doc. MUDr. Aleš Hejčl, Ph.D.1, 2, 3, prof. MUDr. Martin Sameš, CSc.1
1 Neurochirurgická klinika Masarykovy nemocnice a Univerzity Jana Evangelisty Purkyně v Ústí nad Labem
2 Mezinárodní centrum klinického výzkumu v Brně, Cévní program
3 Ústav experimentální medicíny Akademie věd ČR, Praha

Published: April 21, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hejčl A, Sameš M. Hemostyptika u pacientů s rupturou aneuryzmatu
NE! Neurol. praxi. 2022;23(2):176-178. doi: 10.36290/neu.2022.025.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Connolly ES Jr., Rabinstein AA, Carhuapoma JR, American Heart Association Stroke, R. Council on Cardiovascular, Intervention, N. Council on Cardiovascular, S. Council on Cardio­vascular, Anesthesia, C. Council on Clinical, Guidelines for the management of aneurysmal subarachnoid hemor­rhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43(6):1711-1737. Go to original source... Go to PubMed...
    2. Diringer MN, Bleck TP, Hemphill JC, 3rd, et al. Neurocritical Care, Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211-240. Go to original source... Go to PubMed...
    3. Germans MR, Post R, Coert BA, et al. Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial. Trials. 2013;14:143. Go to original source... Go to PubMed...
    4. Hillman J, Fridriksson S, Nilsson O, et al. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97(4):771-778. Go to original source... Go to PubMed...
    5. Hvas CL, Lauridsen SV, Pedersen ES, et al. Ex vivo effect of hemostatic therapy in subarachnoid and intracerebral hemorrhage. Thromb Res. 2020;189:42-47. Go to original source... Go to PubMed...
    6. Kassell NF, Torner JC. Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery. 1983;13(5):479-481. Go to original source... Go to PubMed...
    7. Naidech AM, Janjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemor­rhage. Arch Neurol. 2005;62(3):410-416. Go to original source... Go to PubMed...
    8. Nieuwkamp DJ, Setz LE, Algra A, et al. Rinkel, Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8(7):635-642. Go to original source... Go to PubMed...
    9. Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke. 2001;32(5):1176-1180. Go to original source... Go to PubMed...
    10. Post R, Germans MR, Tjerkstra MA, et al. Investigators, Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet. 2021;397(10269):112-118. Go to original source... Go to PubMed...
    11. Roos Y, Rinkel G, Vermeulen M, et al. Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review. Stroke. 2003;34(9):2308-2309. Go to original source... Go to PubMed...
    12. Rouanet C, Silva GS. Aneurysmal subarachnoid hemorrhage: current concepts and updates. Arq Neuropsiquiatr. 2019;77(11):806-814. Go to original source... Go to PubMed...
    13. Starke RM, Kim GH, Fernandez A, et al. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage. Stroke. 2008;39(9):2617-21. Go to original source... Go to PubMed...
    14. Watts G. Okamoto U. Lancet. 2016;387(10035): 2286. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.